Legal status by country
Is Semaglutide with cagrilintide legal?
Written by Aaron CuhaReviewed Sep 2026
How Semaglutide with cagrilintide is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Not approved; research use only | Not licensed | Not approved | Not approved |
| Note | Semaglutide is approved as a single agent. Cagrilintide is investigational, so a blend containing it is not a lawful medicine and is sold only by research chemical vendors. | Semaglutide is licensed; cagrilintide is not, and supply of the blend for human use is unlawful. | None recorded | None recorded |
US FDA status: The co-formulated combination has been trialled at phase 3 and is the subject of regulatory filings. A research chemical blend sold under its description is not that product and is not approved.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.